Fig. 6
From: Nanomicelles co-loaded with doxorubicin and salvianolic acid A for breast cancer chemotherapy
Evaluation of anticancer characteristics against in vitro proliferation of MCF-7 cells. A Dose–response relationship of free DOX (mean ± SD, n = 6). B Comparison of antiproliferative effect of the preparations related with CPMSD at an equivalent final concentration of 230 ng/mL for DOX, and 920 ng/mL for SAA, respectively (mean ± SD, n = 6; *p < 0.05 compared with DOX in MCF-7, #p < 0.05 compared with DOX in MCF-10A). C CLSM observation (×40 objective) of cellular uptake